Skip to main content
. 2018 Jun 18;9:1355. doi: 10.3389/fimmu.2018.01355

Figure 4.

Figure 4

CXCL9 and IL-6 versus survival in immunotherapy treated patients. CXCL9 (A,B) and IL-6 (C,D) were measured in the serum of ANBL0931 patient samples obtained at pretreatment to course 1. Patient values were sorted as to above or below median levels of all patients and a Kaplan Meier survival analysis for event-free survival (A,C) and OS (B,D) assessed and significance assessed by Log Rank test.